Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

05.07.2021

1 Acta Biomed
1 Acta Histochem
1 Am J Case Rep
1 Ann Med
1 Antioxidants (Basel)
1 Cancer Discov
1 Cancer Res
1 Cancer Sci
5 Cancers (Basel)
1 Cell Cycle
1 Cell Death Dis
1 Clin Transl Med
1 Contemp Clin Trials Commun
1 Cureus
1 Curr Opin Urol
2 Eur Urol
2 Eur Urol Focus
1 Exp Mol Pathol
1 Exp Oncol
1 Expert Opin Investig Drugs
1 Expert Rev Clin Pharmacol
1 Front Immunol
1 Front Mol Biosci
3 Front Oncol
1 Immunotherapy
1 In Vivo
1 Int J Clin Oncol
1 Int J Clin Pract
2 Int J Mol Sci
1 Int J Surg Case Rep
1 Int J Surg Pathol
1 Investig Clin Urol
1 J Cell Mol Med
1 J Clin Lab Anal
1 J Endourol
1 J Immunoassay Immunochem
1 J Magn Reson Imaging
1 J Med Imaging Radiat Oncol
1 J Urol
1 J Vet Intern Med
1 Life (Basel)
1 Mol Immunol
1 Mol Med Rep
2 N Engl J Med
1 Nanomaterials (Basel)
1 Nat Rev Urol
1 Oncol Lett
2 Photodiagnosis Photodyn Ther
1 Sci Rep
1 Urol Int
4 Urol Oncol
1 West Afr J Med
3 World J Urol



    Acta Biomed

  1. OKCU O, Hacihasanoglu E, Koparal MY
    Lymphoepithelioma like carcinoma of the urinary bladder, treated with transurethral resection and intravesical Bacillus Calmette Guerin therapy only: A case report.
    Acta Biomed. 2021;92:e2021031.
    >> Share


    Acta Histochem

  2. FAN L, Yang J, Shen C, Wu Z, et al
    Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis.
    Acta Histochem. 2021;123:151745.
    >> Share


    Am J Case Rep

  3. SUGAYA A, Shimazui T, Kitamura N, Tokita T, et al
    Intra-Abdominal Hypertension-Induced Gastroesophageal Intussusception: A Rare Complication of Transurethral Resection of a Bladder Tumor.
    Am J Case Rep. 2021;22:e930426.
    >> Share


    Ann Med

  4. YAN X, Chen M, Xiao C, Fu J, et al
    Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer.
    Ann Med. 2021;53:1047-1057.
    >> Share


    Antioxidants (Basel)

  5. CHIEN TM, Wu KH, Chuang YT, Yeh YC, et al
    Withaferin A Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress.
    Antioxidants (Basel). 2021;10.
    >> Share


    Cancer Discov


  6. Adjuvant Immunotherapy Best for ctDNA(+) Bladder Cancer.
    Cancer Discov. 2021 Jun 30. pii: 2159-8290.CD-NB2021-0365.
    >> Share


    Cancer Res

  7. WULLWEBER A, Strick R, Lange F, Sikic D, et al
    Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling.
    Cancer Res. 2021;81:1552-1566.
    >> Share


    Cancer Sci

  8. BURNS JE, Hurst CD, Knowles MA, Phillips RM, et al
    The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.
    Cancer Sci. 2021 Jun 28. doi: 10.1111/cas.15047.
    >> Share


    Cancers (Basel)

  9. KOLAT D, Kaluzinska Z, Bednarek AK, Pluciennik E, et al
    WWOX Loses the Ability to Regulate Oncogenic AP-2gamma and Synergizes with Tumor Suppressor AP-2alpha in High-Grade Bladder Cancer.
    Cancers (Basel). 2021;13.
    >> Share

  10. CHUNG DY, Kang DH, Kim JW, Ha JS, et al
    Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.
    Cancers (Basel). 2021;13.
    >> Share

  11. ELDH M, Mints M, Hiltbrunner S, Ladjevardi S, et al
    Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour.
    Cancers (Basel). 2021;13.
    >> Share

  12. ZHANG C, Berndt-Paetz M, Neuhaus J
    A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer.
    Cancers (Basel). 2021;13.
    >> Share

  13. WANG P, Zhou R, Thomas P, Zhao L, et al
    Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems.
    Cancers (Basel). 2021;13.
    >> Share


    Cell Cycle

  14. WANG W, Ying Y, Xie H, Li J, et al
    miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis.
    Cell Cycle. 2021 Jul 1:1-12. doi: 10.1080/15384101.2021.1929677.
    >> Share


    Cell Death Dis

  15. WANG Y, Wu J, Luo W, Zhang H, et al
    ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.
    Cell Death Dis. 2021;12:661.
    >> Share


    Clin Transl Med

  16. LU X, Meng J, Zhu J, Zhou Y, et al
    Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair-based signature.
    Clin Transl Med. 2021;11:e453.
    >> Share


    Contemp Clin Trials Commun

  17. SMITH L, Carrie A, Tully M, Barnett Y, et al
    The CADENCE pilot trial - Promoting physical activity in bladder cancer survivors: A protocol paper.
    Contemp Clin Trials Commun. 2021;22:100809.
    >> Share


    Cureus

  18. ALHUBAISHY B, Mathes J, Knoll T
    Primary Urothelial Bladder Cancer in a Young Patient: A Case Report and Review of the Literature.
    Cureus. 2021;13:e15864.
    >> Share


    Curr Opin Urol

  19. JANSSEN GWB, Ramkumar RR, Lee BH, van der Heijden AG, et al
    Orthotopic urinary diversions after radical cystectomy for bladder cancer: lessons learned last decade.
    Curr Opin Urol. 2021 Jun 25. pii: 00042307-900000000-98856.
    >> Share


    Eur Urol

  20. KULKARNI GS
    Re: Radical Cystectomy Against Intravesical BCG for High-risk High-grade Nonmuscle Invasive Bladder Cancer: Results from the Randomized Controlled BRAVO-feasibility Study.
    Eur Urol. 2021 Jun 23. pii: S0302-2838(21)01803.
    >> Share

  21. HU H
    Re: Richard T. Bryan, Wenyu Liu, Sarah J. Pirrie, et al. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study. Eur Urol 2021;80:12-5.
    Eur Urol. 2021 Jun 29. pii: S0302-2838(21)01859.
    >> Share


    Eur Urol Focus

  22. MICHELS CTJ, Wijburg CJ, Hannink G, Witjes JA, et al
    Robot-assisted Versus Open Radical Cystectomy in Bladder Cancer: An Economic Evaluation Alongside a Multicentre Comparative Effectiveness Study.
    Eur Urol Focus. 2021 Jun 23. pii: S2405-4569(21)00166.
    >> Share

  23. OURFALI S, Matillon X, Ricci E, Fassi-Fehri H, et al
    Prognostic Implications of Treatment Delays for Patients with Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2021 Jun 22. pii: S2405-4569(21)00169.
    >> Share


    Exp Mol Pathol

  24. LIU X, Li H, Che N, Zheng Y, et al
    HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
    Exp Mol Pathol. 2021 Jun 30:104665. doi: 10.1016/j.yexmp.2021.104665.
    >> Share


    Exp Oncol

  25. YAKOVLEV PG, Gorbach OI, Ostapchenko LI, Garmanchuk LV, et al
    Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage.
    Exp Oncol. 2021;43:142-148.
    >> Share


    Expert Opin Investig Drugs

  26. BIN RIAZ I, Khan AM, Catto JW, Hussain SA, et al
    Bladder cancer: shedding light on the most promising investigational drugs in clinical trials.
    Expert Opin Investig Drugs. 2021 Jun 25. doi: 10.1080/13543784.2021.1948999.
    >> Share


    Expert Rev Clin Pharmacol

  27. AHDOOT M, Theodorescu D
    Immunotherapy of high risk non-muscle invasive bladder cancer.
    Expert Rev Clin Pharmacol. 2021 Jun 30. doi: 10.1080/17512433.2021.1950531.
    >> Share


    Front Immunol

  28. CAO C, Fu Z, Liu Y, Zhou A, et al
    A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report.
    Front Immunol. 2021;12:684879.
    >> Share


    Front Mol Biosci

  29. ZHENG H, Chen C
    Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression.
    Front Mol Biosci. 2021;8:692941.
    >> Share


    Front Oncol

  30. MA W, Zhang W, Shen L, Liu J, et al
    Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? A Retrospective Study.
    Front Oncol. 2021;11:677605.
    >> Share

  31. ZHANG G, Wu Z, Xu L, Zhang X, et al
    Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer.
    Front Oncol. 2021;11:654685.
    >> Share

  32. FU G, Cheng KS, Chen A, Xu Z, et al
    Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.
    Front Oncol. 2021;11:701298.
    >> Share


    Immunotherapy

  33. EL GHARIB K, Lilly E, Chebel R
    Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder?
    Immunotherapy. 2021 Jun 29. doi: 10.2217/imt-2021-0030.
    >> Share


    In Vivo

  34. AIBARA N, Miyata Y, Araki K, Sagara Y, et al
    Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study.
    In Vivo. 2021;35:2073-2080.
    >> Share


    Int J Clin Oncol

  35. KAGAWA M, Kawakami S, Yamamoto A, Suzuki O, et al
    Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population.
    Int J Clin Oncol. 2021 Jul 2. pii: 10.1007/s10147-021-01922.
    >> Share


    Int J Clin Pract

  36. ERKOC M, Otunctemur A, Bozkurt M, Can O, et al
    The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Int J Clin Pract. 2021 Jun 29:e14584. doi: 10.1111/ijcp.14584.
    >> Share


    Int J Mol Sci

  37. SURMAN M, Kedracka-Krok S, Jankowska U, Drozdz A, et al
    Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules.
    Int J Mol Sci. 2021;22.
    >> Share

  38. BOTTA C, Agostino RM, Dattola V, Cianci V, et al
    Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune-Biological Evaluation and Case Report.
    Int J Mol Sci. 2021;22.
    >> Share


    Int J Surg Case Rep

  39. HAFIZAR, Hamid ARAH, Saraswati M
    Cystoscopy-assisted laparoscopic partial cystectomy for muscle-invasive bladder cancer: Initial experience in Cipto Mangunkusumo Hospital, Jakarta.
    Int J Surg Case Rep. 2021;84:106083.
    >> Share


    Int J Surg Pathol

  40. GORDETSKY JB, Montgomery KW, Giannico GA, Rais-Bahrami S, et al
    The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Int J Surg Pathol. 2021 Jun 28:10668969211027264. doi: 10.1177/10668969211027264
    >> Share


    Investig Clin Urol

  41. SUH J, Jung JH, Kwak C, Kim HH, et al
    Stratifying risk for multiple, recurrent, and large (>/=3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer.
    Investig Clin Urol. 2021;62:408-415.
    >> Share


    J Cell Mol Med

  42. MUILWIJK T, Akand M, Van der Aa F, De Coninck V, et al
    Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non-muscle-invasive bladder cancer.
    J Cell Mol Med. 2021 Jun 29. doi: 10.1111/jcmm.16712.
    >> Share


    J Clin Lab Anal

  43. ZHAO R, Shan J, Nie L, Yang X, et al
    The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence.
    J Clin Lab Anal. 2021 Jun 29:e23883. doi: 10.1002/jcla.23883.
    >> Share


    J Endourol

  44. PATEL NH, Miranda G, Cai J, Desai M, et al
    Robotic Radical Cystectomy Outcomes after Intervention for Prostate Cancer.
    J Endourol. 2021;35:633-638.
    >> Share


    J Immunoassay Immunochem

  45. ABDALLAH MM, Wahbbah MA, Selem M, Abdou AG, et al
    Correlation between immunohistochemical expression of Ki-67and P63 and aggressiveness of urinary bladder urothelial carcinoma.
    J Immunoassay Immunochem. 2021;42:188-201.
    >> Share


    J Magn Reson Imaging

  46. CAO B, Li Q, Xu P, Chen W, et al
    Preliminary Exploration of the Application of Vesical Imaging-Reporting and Data System (VI-RADS) in Post-treatment Patients With Bladder Cancer: A Prospective Single-Center Study.
    J Magn Reson Imaging. 2021 Jun 28. doi: 10.1002/jmri.27807.
    >> Share


    J Med Imaging Radiat Oncol

  47. ANZELA A, Min M, Knesl M, Buddle N, et al
    Concurrent carbogen and nicotinamide with radiation therapy in muscle invasive bladder cancer: A report on feasibility in the Australian setting.
    J Med Imaging Radiat Oncol. 2021 Jun 30. doi: 10.1111/1754-9485.13265.
    >> Share


    J Urol

  48. MICHELLE R, Liguori G, Trombetta C
    Antimicrobial Prophylaxis for Postoperative Urinary Tract Infections in Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-analysis. Letter.
    J Urol. 2021 Feb 12:101097JU0000000000001649. doi: 10.1097/JU.0000000000001649.
    >> Share


    J Vet Intern Med

  49. BUTTY EM, Hahn S, Labato MA
    Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog.
    J Vet Intern Med. 2021;35:1551-1557.
    >> Share


    Life (Basel)

  50. SIKIC D, Taubert H, Wirtz RM, Breyer J, et al
    High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
    Life (Basel). 2021;11.
    >> Share


    Mol Immunol

  51. MU X, Wu K, Zhu Y, Zhu Y, et al
    Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the fi brocytic myeloid-derived suppressor cells in an m6A-dependent manner.
    Mol Immunol. 2021;137:28-40.
    >> Share


    Mol Med Rep

  52. LU J, Luo JH, Pang J, Cao JZ, et al
    [Corrigendum] Lentivirusmediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
    Mol Med Rep. 2021;24.
    >> Share


    N Engl J Med

  53. PETRYLAK DP, Powles T, Rosenberg JE
    Enfortumab Vedotin in Advanced Urothelial Carcinoma. Reply.
    N Engl J Med. 2021;385:93-94.
    >> Share

  54. YEON SH, Lee HJ
    Enfortumab Vedotin in Advanced Urothelial Carcinoma.
    N Engl J Med. 2021;385:93.
    >> Share


    Nanomaterials (Basel)

  55. RINALDI F, Maurizi L, Forte J, Marazzato M, et al
    Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells.
    Nanomaterials (Basel). 2021;11.
    >> Share


    Nat Rev Urol

  56. LI R, Zhang J, Gilbert SM, Conejo-Garcia J, et al
    Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer.
    Nat Rev Urol. 2021 Jun 28. pii: 10.1038/s41585-021-00483.
    >> Share


    Oncol Lett

  57. ZHU J, Huang Z, Zhang M, Wang W, et al
    Erratum: HIF-1alpha promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model.
    Oncol Lett. 2021;22:599.
    >> Share


    Photodiagnosis Photodyn Ther

  58. NAKATANI S, Ida M, Wang X, Naito Y, et al
    Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis.
    Photodiagnosis Photodyn Ther. 2021;34:102342.
    >> Share

  59. PAGLIARONE AC, Castaneda ED, Santana JPP, de Oliveira CAB, et al
    Mitochondrial heat shock protein mortalin as potential target for therapies based on oxidative stress.
    Photodiagnosis Photodyn Ther. 2021;34:102256.
    >> Share


    Sci Rep

  60. BLOMQVIST M, Koskinen I, Loyttyniemi E, Mirtti T, et al
    Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer.
    Sci Rep. 2021;11:13684.
    >> Share


    Urol Int

  61. GAO T, Ji Y
    Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
    Urol Int. 2021 Jun 30:1-15. doi: 10.1159/000514388.
    >> Share


    Urol Oncol

  62. NAGAKAWA S, Shiota M, Fujimoto N, Yamamoto Y, et al
    The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer in a genome-wide association study.
    Urol Oncol. 2021 Jun 29. pii: S1078-1439(21)00254.
    >> Share

  63. MIRANDA AF, Howard JM, McLaughlin M, Meng X, et al
    Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.
    Urol Oncol. 2021 Jun 29. pii: S1078-1439(21)00212.
    >> Share

  64. SHORE ND, Palou Redorta J, Robert G, Hutson TE, et al
    Non-muscle-invasive bladder cancer: An overview of potential new treatment options.
    Urol Oncol. 2021 Jun 21. pii: S1078-1439(21)00221.
    >> Share

  65. ISMAEEL N, Patil D, Alemozaffar M, Filson CP, et al
    Palliative care use among bladder cancer patients treated with radical cystectomy.
    Urol Oncol. 2021 Jun 23. pii: S1078-1439(21)00186.
    >> Share


    West Afr J Med

  66. KARIKALAN B, Pasupati T, George SM
    Primary Mucinous Adenocarcinoma of the Urinary Bladder: A Rare Entity.
    West Afr J Med. 2021;38:604-606.
    >> Share


    World J Urol

  67. XIA QD, Hu J, Liu Z, Li C, et al
    Sex differences resulted differential morbidity and mortality in bladder cancer: smoke, hormone or urobiome?
    World J Urol. 2021 Jul 1. pii: 10.1007/s00345-021-03775.
    >> Share

  68. BARON P, Khene Z, Lannes F, Pignot G, et al
    Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer.
    World J Urol. 2021 Jul 3. pii: 10.1007/s00345-021-03753.
    >> Share

  69. CLAPS F, van de Kamp MW, Mayr R, Bostrom PJ, et al
    Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.
    World J Urol. 2021 Jul 1. pii: 10.1007/s00345-021-03776.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016